Method of evaluation of tuberculocidal effectiveness of disinfectants in clinical strains of Mycobacterium tuberculosis

N. Eremeeva (Yekaterinburg, Russian Federation)

Source: Annual Congress 2010 - Special treatment options in tuberculosis
Session: Special treatment options in tuberculosis
Session type: Thematic Poster Session
Number: 3132
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Eremeeva (Yekaterinburg, Russian Federation). Method of evaluation of tuberculocidal effectiveness of disinfectants in clinical strains of Mycobacterium tuberculosis. Eur Respir J 2010; 36: Suppl. 54, 3132

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of macrolides for possible use against multidrug-resistant Mycobacterium tuberculosis
Source: Eur Respir J 2015; 46: 444-455
Year: 2015



Estimation of susceptibility hospital strains of Mycobacterium tuberculosis (Mtb) Beijing to disinfectants
Source: International Congress 2017 – Paediatric TB: MDRTB (II)
Year: 2017

Evaluation of a molecular assay for detection of rifampin and isoniazid resistant mycobacterium tuberculosis in strains and clinical samples
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008


Considerations upon the drug resistance spectrum of Mycobacterium tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 313s
Year: 2001

Clinical efficacy and safety of fluoroquinolone containing regimens in patients with Mycobacterium avium complex pulmonary disease
Source: Eur Respir J, 55 (4) 1901240; 10.1183/13993003.01240-2019
Year: 2020



Characteristics of drug susceptibility testing for bedaquline and clofazimine of 178 drug-resistant Mycobacterium tuberculosis isolates in Japan
Source: International Congress 2019 – Drug-resistant tuberculosis
Year: 2019



Assessment of the clinical utility of amplicor mycobacterium tuberculosis direct test during bacteriological confirmation of tuberculosis in children
Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents
Year: 2008

Biological properties of Mycobacterium tuberculosis (Mtb) resistant to biocides
Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis
Year: 2021


The effect of tobacco smoking on drug sensitivity and microbiological characteristics of Mycobacterium tuberculosis (MTB): clinical and experimental study
Source: Eur Respir J 2003; 22: Suppl. 45, 158s
Year: 2003

Determination of drug susceptibility of Mycobacterium tuberculosis through mycolic acid analysis with HPLC technique - comparison to the conventional methods
Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Year: 2005


Evaluation of treatment outcomes for multidrug-resistant tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 312s
Year: 2001

Comparison of rapid in-house methods for drug susceptibility testing of mycobacterium tuberculosis with gold standards
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007


Comparison of performance in two diagnostic methods for M. tuberculosis infection
Source: Annual Congress 2008 - New tools in tuberculosis diagnosis
Year: 2008


Results of drug susceptibility testing of Mycobacterium tuberculosis isolated from sputum and surgical material from pulmonary tuberculosis patients
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020


The Glutoxim influence on minimum inhibitory concentration of isoniazid-resistant strains of Mycobacterium tuberculosis
Source: International Congress 2019 – Tuberculosis: from basic science to patient care
Year: 2019

Bedaquiline as a potential agent in the treatment of Mycobacterium abscessus infections
Source: Eur Respir J, 49 (5) 1700083; 10.1183/13993003.00083-2017
Year: 2017



Results of multicentral external quality assessment for M. tuberculosis drug susceptibility testing in Russia
Source: Eur Respir J 2005; 26: Suppl. 49, 646s
Year: 2005

Routine survey of Mycobacterium tuberculosis isolates reveals nosocomial transmission
Source: Eur Respir J, 55 (3) 1901888; 10.1183/13993003.01888-2019
Year: 2020



Comparative analysis of detection of Mycobacterium tuberculosis and rifampin resistance determination through microbiological and molecular genetics methods for pulmonary tuberculosis patients with presence or absence of sputum
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012


In vitro susceptibility testing of bedaquiline against mycobacteria avium-intracellulare complex
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020